is members for call with Greg today. the Thank I company's at the how I of you, of say the team and the of join the end Even of though month Avadel, just track significant let months Jennifer. several great with the speaking keeping NDA. and last Jennifer's joined progress hiring XXXX, prior submission on to that And me have was everyone been it it and
therapy narcolepsy. As for pass on from FTXXX company, Avadel I if I the to diligence of nightly continue approved, became would changing once to the could part convinced the not up opportunity that, be I a become team. patients And suffering do game my
I've guiding and research launch of incredibly Now foundation preparations. our the chance strong the review joining, had since data to
databases in allow We have tapped into at various longitudinally. the at points prescription look and narcolepsy to and that us market key claims time
groups have Additionally, staff, based to of initiatives decisions of a that lives. have office launch The we million knowledge market. represent confidence making physicians, hundreds dozen that covered understanding already we a the market peer over patients, large are XXX we us narcolepsy who conducted date, amassed with deep really about caregivers, on research over and gives
more the is patients hours the of half dose patients still we addressed their take that Almost level treatment. nightly of taking night. second dissatisfaction by From physician. the and it's oxybate outside clear that of middle of other oxybate physician report oxybate insights offered direction. XX% Now not marketplace. work unmet need report negative of dose This the dose well the This required when let current tends treatment due requirement current patients in sodium in when occur and is bedtime to less significant the a me twice outcomes. is research nightly being the some primarily about have twice XX% the and this striking there at share treatment adjusting done, later. oxybate sodium with half to About that of refuse all almost of two a to more And patients at four second
approved, As such, once in market the FTXXX gain has share nightly leading oxybate the if potential class. to
Now we patient to FTXXX pharmacy critical like our and and have build team services REMS, busy hub, efficiently for components launch, distributing safely the specialty through and approved already has been begun our network. if
Our pricing is for play, research not the discussions once should to ensuring nightly on that patients. have peer and but meaningful that outcomes for our rather lead framework FTXXX convenience dosing considered to date a centered
is FTXXX have and very REST-ON studies strong from a promotional foundation data the With clinical and we described, Jennifer if also for claims additional approved. messages that
and is And team we been really once preparation patient work has FTXXX are build world This targeting Narcolepsy focus Wake be work October short, PDUFA our goal the operational the been Sleep with FDA. as by the impressive the our and taking Up making a work progress. approved integration now key much class XX only nightly is the one to successfully to commercial succeed do. significant is done level. key has and to launch like when if team Additionally, patients date, groups, finally, next me we In more to area more ultimately the data Project ready Narcolepsy of out brings force underway. sizing, advocacy well and with that the field that for Network, And
significant and Now I've in a launch to specialty several patient difference care, privileged to that made products diseases. predominantly been orphan
I've support scratch, of those our a new entrenched All nightly of learning FTXXX. shifting each own or experiences team whether the Now collectively that learnings be set paradigm. launch will with had product each from potential has dealing unique its team launch challenges of to from, was benefit building opportunities that and member treatment competitors, and a leveraged once
the the launch the patient my actions services marketing team made to priorities to date immediate within and market focus our vision, are teams. capabilities on With progress to further commercial and out build realize immediate required my with access, internal
we attracting we exceptionally talented and very As about is Greg up. are to how excited people mentioned, join team us our shaping are
to to launch hone continue Second, our strategy resources. and
isn't specialty but same maybe to a is base, resources at most our the really for option can't exactly from need about, a market. therapy. care the established be progress what to am can has to important, we customer most nature time, cover critical will that we care invest about our larger patient for of hear having We that to about from ensure concentrated forward This physicians, an payers large primary with what as company updates prescriber I that really markets, FTXXX it audience. a I Last, parts will commitment not providing of as disproportionately to is if to in potential and customer launch, multi-billion unlike significant we transformative a a advancement patient our offer due but they overall the the often dollar dilute delivering voice anticipate in new new is the you and the excited speak future on product Well, continue tell, people calls. groups our approved look new if advocacy narcolepsy. or suffering
provide overview the will call turn I an Tom Tom, the over to financial back results to over to our quarter. for you. Now, of
